共 50 条
- [34] The CLARITY study (CLAdRIbine tablets Treating multiple sclerosis orallY): design of a Phase III trial of oral cladribine in relapsing multiple sclerosis MULTIPLE SCLEROSIS, 2007, 13 : S245 - S245
- [35] CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):